Safety and efficacy of [177Lu]Lu-SibuDAB in patients with progressive metastatic castration-resistant prostate cancer.
Saved in:
| Title: | Safety and efficacy of [177Lu]Lu-SibuDAB in patients with progressive metastatic castration-resistant prostate cancer. |
|---|---|
| Authors: | Fernández R; Center for Nuclear Medicine & PET/CT PositronMed, Providencia, Santiago, 7501068, Chile. rfernandez@positronmed.cl., Soza-Ried C; Center for Nuclear Medicine & PET/CT PositronMed, Providencia, Santiago, 7501068, Chile.; Positronpharma SA, Providencia, Santiago, 7501068, Chile.; Facultad de Medicina Veterinaria y Agronomía, Instituto de Ciencias Naturales, Universidad de las Américas, Santiago, Chile., Kramer V; Center for Nuclear Medicine & PET/CT PositronMed, Providencia, Santiago, 7501068, Chile.; Positronpharma SA, Providencia, Santiago, 7501068, Chile., Krieger K; Center for Radiopharmaceutical Sciences, PSI, Center for Life Sciences, Villigen-PSI, 5232, Switzerland.; Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, 8093, Switzerland., Müller C; Center for Radiopharmaceutical Sciences, PSI, Center for Life Sciences, Villigen-PSI, 5232, Switzerland.; Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, 8093, Switzerland., Qin Y; ITM Oncologics GmbH, Lichtenbergstrasse 1, Garching, Munich, 85748, Germany., Fliegert F; ITM Oncologics GmbH, Lichtenbergstrasse 1, Garching, Munich, 85748, Germany., Ritt P; ITM Oncologics GmbH, Lichtenbergstrasse 1, Garching, Munich, 85748, Germany., Zhernosekov K; ITM Oncologics GmbH, Lichtenbergstrasse 1, Garching, Munich, 85748, Germany., Amaral H; Center for Nuclear Medicine & PET/CT PositronMed, Providencia, Santiago, 7501068, Chile.; Positronpharma SA, Providencia, Santiago, 7501068, Chile., Estay R; Center for Nuclear Medicine & PET/CT PositronMed, Providencia, Santiago, 7501068, Chile.; Departamento de Medicina Interna Oriente, Universidad de Chile, Servicio de Oncología, Hospital Salvador, Santiago, Chile., Nicolai H; Center for Nuclear Medicine & PET/CT PositronMed, Providencia, Santiago, 7501068, Chile.; Departamento de Urología, Universidad de Chile, Hospital San Borja Arriarán, Santiago, Chile. |
| Source: | European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2026 Mar; Vol. 53 (4), pp. 2282-2294. Date of Electronic Publication: 2025 Nov 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41201599 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and efficacy of [<superscript>177</superscript>Lu]Lu-SibuDAB in patients with progressive metastatic castration-resistant prostate cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fernández+R%22">Fernández R</searchLink>; Center for Nuclear Medicine & PET/CT PositronMed, Providencia, Santiago, 7501068, Chile. rfernandez@positronmed.cl.<br /><searchLink fieldCode="AU" term="%22Soza-Ried+C%22">Soza-Ried C</searchLink>; Center for Nuclear Medicine & PET/CT PositronMed, Providencia, Santiago, 7501068, Chile.; Positronpharma SA, Providencia, Santiago, 7501068, Chile.; Facultad de Medicina Veterinaria y Agronomía, Instituto de Ciencias Naturales, Universidad de las Américas, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Kramer+V%22">Kramer V</searchLink>; Center for Nuclear Medicine & PET/CT PositronMed, Providencia, Santiago, 7501068, Chile.; Positronpharma SA, Providencia, Santiago, 7501068, Chile.<br /><searchLink fieldCode="AU" term="%22Krieger+K%22">Krieger K</searchLink>; Center for Radiopharmaceutical Sciences, PSI, Center for Life Sciences, Villigen-PSI, 5232, Switzerland.; Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, 8093, Switzerland.<br /><searchLink fieldCode="AU" term="%22Müller+C%22">Müller C</searchLink>; Center for Radiopharmaceutical Sciences, PSI, Center for Life Sciences, Villigen-PSI, 5232, Switzerland.; Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, 8093, Switzerland.<br /><searchLink fieldCode="AU" term="%22Qin+Y%22">Qin Y</searchLink>; ITM Oncologics GmbH, Lichtenbergstrasse 1, Garching, Munich, 85748, Germany.<br /><searchLink fieldCode="AU" term="%22Fliegert+F%22">Fliegert F</searchLink>; ITM Oncologics GmbH, Lichtenbergstrasse 1, Garching, Munich, 85748, Germany.<br /><searchLink fieldCode="AU" term="%22Ritt+P%22">Ritt P</searchLink>; ITM Oncologics GmbH, Lichtenbergstrasse 1, Garching, Munich, 85748, Germany.<br /><searchLink fieldCode="AU" term="%22Zhernosekov+K%22">Zhernosekov K</searchLink>; ITM Oncologics GmbH, Lichtenbergstrasse 1, Garching, Munich, 85748, Germany.<br /><searchLink fieldCode="AU" term="%22Amaral+H%22">Amaral H</searchLink>; Center for Nuclear Medicine & PET/CT PositronMed, Providencia, Santiago, 7501068, Chile.; Positronpharma SA, Providencia, Santiago, 7501068, Chile.<br /><searchLink fieldCode="AU" term="%22Estay+R%22">Estay R</searchLink>; Center for Nuclear Medicine & PET/CT PositronMed, Providencia, Santiago, 7501068, Chile.; Departamento de Medicina Interna Oriente, Universidad de Chile, Servicio de Oncología, Hospital Salvador, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Nicolai+H%22">Nicolai H</searchLink>; Center for Nuclear Medicine & PET/CT PositronMed, Providencia, Santiago, 7501068, Chile.; Departamento de Urología, Universidad de Chile, Hospital San Borja Arriarán, Santiago, Chile. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101140988%22">European journal of nuclear medicine and molecular imaging</searchLink> [Eur J Nucl Med Mol Imaging] 2026 Mar; Vol. 53 (4), pp. 2282-2294. <i>Date of Electronic Publication: </i>2025 Nov 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+Berlin%22">Springer-Verlag Berlin </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101140988 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1619-7089 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216197070%22">16197070 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Nucl Med Mol Imaging <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41201599 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00259-025-07634-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2282 Titles: – TitleFull: Safety and efficacy of [177Lu]Lu-SibuDAB in patients with progressive metastatic castration-resistant prostate cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fernández R – PersonEntity: Name: NameFull: Soza-Ried C – PersonEntity: Name: NameFull: Kramer V – PersonEntity: Name: NameFull: Krieger K – PersonEntity: Name: NameFull: Müller C – PersonEntity: Name: NameFull: Qin Y – PersonEntity: Name: NameFull: Fliegert F – PersonEntity: Name: NameFull: Ritt P – PersonEntity: Name: NameFull: Zhernosekov K – PersonEntity: Name: NameFull: Amaral H – PersonEntity: Name: NameFull: Estay R – PersonEntity: Name: NameFull: Nicolai H IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2026 Mar Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1619-7089 Numbering: – Type: volume Value: 53 – Type: issue Value: 4 Titles: – TitleFull: European journal of nuclear medicine and molecular imaging Type: main |
| ResultId | 1 |